Kana Hasegawa

Kana Hasegawa

Auto-generated profile, based on publicly available information

Kana Hasegawa

Laboratory of Cellular Immunotherapy, World Premier International Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2022 in Science Translational Medicine
Verified
Journal Article
Open access
KHKana Hasegawa
Kana Hasegawa
SIShunya Ikeda
Shunya Ikeda
MYMoto Yaga
Moto Yaga
KWKouki Watanabe
Kouki Watanabe
RURika Urakawa
Rika Urakawa
NHNaoki Hosen
Naoki Hosen
Cancer-specific cell surface antigens are ideal therapeutic targets for monoclonal antibody (mAb)–based therapy. Here, we report that multiple myeloma (MM), an incurable hematological malignancy, can be specifically targeted by an mAb that recognizes a ubiquitously present protein, CD98 heavy chain (hc) (also known as SLC3A2). We screened more than 10,000 mAb clones raised against MM cells and identified R8H283, an mAb that bound MM cells but not normal hematopoietic or nonhematopoietic cells. R8H283 specifically recognized CD98hc. R8H283 did not react with monomers of CD98hc; instead, it bound CD98hc in heterodimers with a CD98 light chain (CD98lc), a complex that functions as an amino acid transporter. CD98 heterodimers were abundant on MM cells and took up amino acids for constitutive production of immunoglobulin. Although CD98 heterodimers were also present on normal leukocytes, R8H283 did not react with them. The glycoforms of CD98hc present on normal leukocytes were distinct from those present on MM cells, which may explain the lack of R8H283 reactivity to normal leukocytes. R8H283 exerted anti-MM effects without damaging normal hematopoietic cells. These findings suggested that R8H283 is a candidate for mAb-based therapies for MM. In addition, our findings showed that a cancer-specific conformational epitope in a ubiquitous protein, which cannot be identified by transcriptome or proteome analyses, can be found by extensive screening of primary human tumor samples.

23 May 2017 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
JNJun Nakata
Jun Nakata
YNYoshiki Nakae
Yoshiki Nakae
MKManabu Kawakami
Manabu Kawakami
SMSoyoko Morimoto
Soyoko Morimoto
DMDaisuke Motooka
Daisuke Motooka
HSHaruo Sugiyama
Haruo Sugiyama